Critical role of the GM-CSF signaling pathway in macrophage pro-repair activities

Pathobiology

Volumn 81, Issue 4, 2014, Pages 183-189

  Bernasconi, Eric ^a   D'Angelo, Fabrizia ^a   Michetti, Pierre ^a   Velin, Dominique ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Crohn's disease; Inflammatory bowel diseases; Intestinal ulcers; Macrophages; Mucosal healing

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; CROHN DISEASE; FEMALE; IN VITRO STUDY; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; SIGNAL TRANSDUCTION; WOUND HEALING; ANIMAL; BAGG ALBINO MOUSE; CACO 2 CELL LINE; EPITHELIUM CELL; HUMAN; IMMUNOLOGY; MALE; METABOLISM; PHYSIOLOGY;

ANIMALS; BONE MARROW CELLS; CACO-2 CELLS; CROHN DISEASE; EPITHELIAL CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MONOCYTES; RECEPTORS, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 84906630810     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000365395     Document Type: Article

References (26)

1. Leibovich SJ, Ross R: The role of the macrophage in wound repair: A study with hydrocortisone and antimacrophage serum. Am J Pathol 1975; 78: 71-100.
2. Lucas T, Waisman A, Ranjan R, Roes J, Krieg T, Muller W, Roers A, Eming SA: Differential roles of macrophages in diverse phases of skin repair. J Immunol 2010; 184: 3964-3977.
3. Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP, Elson CO: Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994; 107: 1643-1652.
4. Qualls JE, Kaplan AM, Van Rooijen N, Cohen DA: Suppression of experimental colitis by intestinal mononuclear phagocytes. J Leukoc Biol 2006; 80: 802-815.
5. Bernasconi E, Favre L, Maillard MH, Bachmann D, Pythoud C, Bouzourene H, Croze E, Velichko S, Parkinson J, Michetti P, Velin D: Granulocyte-macrophage colony-stimulating factor elicits bone marrow-derived cells that promote efficient colonic mucosal healing. Inflamm Bowel Dis 2010; 16: 428-441.
6. D'Angelo F, Bernasconi E, Schafer M, Moyat M, Michetti P, Maillard MH, Velin D: Macrophages promote epithelial repair through hepatocyte growth factor secretion. Clin Exp Immunol 2013; 174: 60-72.
7. Sartor RB: Microbial influences in inflammatory bowel diseases. Gastroenterology 2008; 134: 577-594.
8. Kamada N, Hisamatsu T, Okamoto S, Chinen H, Kobayashi T, Sato T, Sakuraba A, Kitazume MT, Sugita A, Koganei K, Akagawa KS, Hibi T: Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis. J Clin Invest 2008; 118: 2269-2280.
9. Smith AM, Rahman FZ, Hayee B, Graham SJ, Marks DJ, Sewell GW, Palmer CD, Wilde J, Foxwell BM, Gloger IS, Sweeting T, Marsh M, Walker AP, Bloom SL, Segal AW: Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J Exp Med 2009; 206: 1883-1897.
10. Casanova JL, Abel L: Revisiting Crohn's disease as a primary immunodeficiency of macrophages. J Exp Med 2009; 206: 1839-1843.
11. Hamilton JA: Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 2008; 8: 533-544.
12. Hirata Y, Egea L, Dann SM, Eckmann L, Kagnoff MF: GM-CSF-facilitated dendritic cell recruitment and survival govern the intestinal mucosal response to a mouse enteric bacterial pathogen. Cell Host Microbe 2010; 7: 151-163.
13. Xu Y, Hunt NH, Bao S: The role of granulocyte macrophage-colony-stimulating factor in acute intestinal inflammation. Cell Res 2008; 18: 1220-1229.
14. Egea L, McAllister CS, Lakhdari O, Minev I, Shenouda S, Kagnoff MF: GM-CSF produced by nonhematopoietic cells is required for early epithelial cell proliferation and repair of injured colonic mucosa. J Immunol 2013; 190: 1702-1713.
15. Korzenik JR, Dieckgraefe BK, Valentine JF, Hausman DF, Gilbert MJ; Sargramostim in Crohn's Disease Study Group: Sargramostim for active Crohn's disease. N Engl J Med 2005; 352: 2193-2201.
16. Krause SW, Kreutz M, Zenke G, Andreesen R: Developmental regulation of granulocytemacrophages colony-stimulating factor during human monocyte-to-macrophage maturation. Ann Hematol 1992; 64: 190-195.
17. Pull SL, Doherty JM, Mills JC, Gordon JI, Stappenbeck TS: Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc Natl Acad Sci USA 2005; 102: 99-104.
18. Seno H, Miyoshi H, Brown SL, Geske MJ, Colonna M, Stappenbeck TS: Efficient colonic mucosal wound repair requires Trem2 signaling. Proc Natl Acad Sci USA 2009; 106: 256-261.
19. Sainathan SK, Hanna EM, Gong Q, Bishnupuri KS, Luo Q, Colonna M, White FV, Croze E, Houchen C, Anant S, Dieckgraefe BK: Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis. Inflamm Bowel Dis 2008; 14: 88-99.
20. Mosser DM, Edwards JP: Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958-969.
21. Han X, Uchida K, Jurickova I, Koch D, Willson T, Samson C, Bonkowski E, Trauernicht A, Kim MO, Tomer G, Dubinsky M, Plevy S, Kugathsan S, Trapnell BC, Denson LA: Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease. Gastroenterology 2009; 136: 1261-1271, e1261-e1263.
22. Goldstein JI, Kominsky DJ, Jacobson N, Bowers B, Regalia K, Austin GL, Yousefi M, Falta MT, Fontenot AP, Gerich ME, Golden-Mason L, Colgan SP: Defective leukocyte GMCSF receptor (CD116) expression and function in inflammatory bowel disease. Gastroenterology 2011; 141: 208-216.
23. Dieckgraefe BK, Korzenik JR: Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor. Lancet 2002; 360: 1478-1480.
24. Feagan BG, Anderson F, Radford-Smith GL, Solovyov O, Zurdel-Dillinger S: Efficacy and safety of sargramostim in moderate to severe Crohn's disease: Results of Novel 4, a phase III multicenter study. Gastroenterology 2007; 132: A103.
25. Hunter MM, Wang A, Parhar KS, Johnston MJ, Van Rooijen N, Beck PL, McKay DM: In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice. Gastroenterology 2010; 138: 1395-1405.
26. Enderlin Vaz da Silva Z, Lehr HA, Velin D: In vitro and in vivo repair activities of undifferentiated and classically and alternatively activated macrophages. Pathobiology 2014; 81: 86-93.